Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000947871-23-000478
Filing Date
2023-04-19
Accepted
2023-04-19 19:55:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3213
  Complete submission text file 0000947871-23-000478.txt   4782
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: 144

Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Subject) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39130 | Film No.: 23831117
SIC: 3841 Surgical & Medical Instruments & Apparatus